IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
This Quarter Return
+14.86%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$366M
AUM Growth
+$56.4M
(+18%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
8.51%
Top 10 Holdings %
Top 10 Hldgs %
57.01%
Holding
57
New
4
Increased
13
Reduced
4
Closed
5
Top Buys
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.3M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$9.56M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$8.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$7.67M |
| 5 |
Amgen
AMGN
|
$6.44M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$18.9M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$8.98M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$4.22M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$4.04M |
| 5 |
Biogen
BIIB
|
$2.64M |
Sector Composition
| 1 | Healthcare | 95.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEAL
51
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $203K | 0.06% |
5,653
| – | – |
|
52
Cytokinetics
CYTK
$5.98B
| – | – |
-25,000
| Closed | -$541K |
|
53
Immunic
IMUX
$79.4M
| – | – |
-123,000
| Closed | -$2.28M |
|
|
ARNA
54
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-16,500
| Closed | -$1.23M |
|
|
MYOK
55
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-65,859
| Closed | -$8.98M |
|
|
IMMU
56
DELISTED
Immunomedics Inc
IMMU
| – | – |
-49,700
| Closed | -$4.22M |
|